www.komodohealth.com
Year invested: 2025
Sector: Healthcare IT

Company Overview

Komodo is a data and analytics software platform that provides high-fidelity, actionable insights to healthcare and life sciences companies. The Company’s cloud-native platform ingests and standardizes large volumes of de-identified patient information from open and proprietary sources into a consolidated data asset, the “Healthcare Map,” which offers a detailed view of patient trends across the U.S. healthcare system. Komodo leverages this data asset across multiple software applications featuring user-friendly dashboards and out-of-the-box analytics. The platform empowers decision-makers to identify patient populations, uncover treatment patterns, and validate health outcomes amid rising demand for real-time insights across the drug development lifecycle. Founded in 2014, Komodo has ~750 employees and is headquartered in New York City.

Investment Thesis

Komodo is a market-leading intelligence platform for the healthcare and life sciences industry, and a vendor of choice among blue-chip pharma companies for data quality and time-to-value. It offers the industry’s broadest and richest patient database, with over 300 million lives covered and a deep moat built on advanced data processing and out-of-the-box analytics. The Healthcare Map is a regulatory-grade data asset, which is refreshed daily and integrates siloed information into a longitudinal view of de-identified patients’ complete medical journeys.

We believe Komodo is a beneficiary of multiple secular tailwinds and emerging growth opportunities. The proliferation of healthcare data and rapid advances in AI are enabling new use cases for sophisticated analytics tools. Regulatory requirements, the rising cost of healthcare, and the shift towards evidence-based care are driving demand for robust monitoring of the drug development lifecycle and patient outcomes. Innovations in personalized medicine require high-quality intelligence to tailor treatment approaches to individuals. Komodo’s no-code, low-code, and developer-friendly platform democratizes access to these insights. The Company plays a mission-critical role in a resilient end market and continues to invest in product expansion and channel partnerships to drive growth. As an investor, we are excited to support Komodo’s mission and vision.